Influence of dietary iodine deficiency on the thyroid gland in Slc26a4-null mutant mice
© Iwata et al; licensee BioMed Central Ltd. 2011
Received: 24 February 2011
Accepted: 20 June 2011
Published: 20 June 2011
Pendred syndrome (PDS) is an autosomal recessive disorder characterized by sensorineural hearing impairment and variable degree of goitrous enlargement of the thyroid gland with a partial defect in iodine organification. The thyroid function phenotype can range from normal function to overt hypothyroidism. It is caused by loss-of-function mutations in the SLC26A4 (PDS) gene. The severity of the goiter has been postulated to depend on the amount of dietary iodine intake. However, direct evidence has not been shown to support this hypothesis. Because Slc26a4-null mice have deafness but do not develop goiter, we fed the mutant mice a control diet or an iodine-deficient diet to evaluate whether iodine deficiency is a causative environmental factor for goiter development in PDS.
We evaluated the thyroid volume in histological sections with the use of three-dimensional reconstitution software, we measured serum levels of total tri-iodothyronine (TT3) and total thyroxine (TT4) levels, and we studied the thyroid gland morphology by transmission electron microscopy.
TT4 levels became low but TT3 levels did not change significantly after eight weeks of an iodine-deficient diet compared to levels in the control diet animals. Even in Slc26a4-null mice fed an iodine-deficient diet, the volume of the thyroid gland did not increase although the size of each epithelial cell increased with a concomitant decrease of thyroid colloidal area.
An iodine-deficient diet did not induce goiter in Slc26a4-null mice, suggesting that other environmental, epigenetic or genetic factors are involved in goiter development in PDS.
Pendred syndrome (PDS) is an autosomal recessive disorder characterized by sensorineural hearing impairment, presence of goiter, and a partial defect in iodine organification . The goiter in PDS is variable in its presentation; it can develop at any age (although generally after puberty), but may be totally absent in some affected individuals . Also, there is substantial intrafamilial and regional variation, and nutritional iodine intake may be a significant modifier of the thyroid phenotype . Kopp et al. suggested that under conditions of sufficient iodine intake, thyroid enlargement may be very mild or absent, and hence these patients are often simply categorized as having enlarged vestibular aqueduct . Sato et al. also suggested that even in patients with impaired iodide transport, high iodine intake may prevent the development of goiter .
Slc26a4-null (Slc26a4 -/- ) mutant mice were generated by Everett et al. . Slc26a4 -/- mice are profoundly deaf with vestibular dysfunction, but they lack goiter and thyroid histological abnormalities. We hypothesized that the absence of goiter and hypothyroidism in Slc26a4 -/- mice was due to a sufficient iodine intake, and that goiter and hypothyroidism might be induced by iodine deficiency. We, therefore, performed this study to investigate the influence of iodine intake on serum thyroid hormone levels and the histology and volume of the thyroid gland in Slc26a4 -/- mice.
Materials and methods
An Slc26a4-null (Slc26a4 -/- ) mouse colony was established and bred with homozygotes and heterozygotes imported from the National Institutes of Health (Rockville, Maryland) . The line was maintained on a 129/SvEv background.
Breeding and Diet
Total tri-iodothyronine (TT3) and total thyroxine (TT4) levels and thyroid volumes in Slc26a4-null mice eating control chow (CCD) or iodine-deficient chow (ICD).
Body weight (g)
Serum thyroid hormones
After deep anesthesia by intraperitoneal injection of pentobarbital sodium, blood was collected from the inferior vena cava. Serum total tri-iodothyronine (TT3) and total thyroxine (TT4) levels were measured by an electrochemiluminescence immunoassay (TT3: DRG® T-3 ELISA, TT4: DRG® T-4 ELISA, DRG International, East Mountainside, New Jersey USA).
Thyroid histology and volume
After intracardiac infusion of 4% paraformaldehyde, thyroid glands were excised together with adjacent tracheae and immersed in the same fixative for 24 hours at 4°C. The specimens were placed in 10% EDTA for seven days, washed with phosphate buffered saline (PBS), embedded in paraffin, and sectioned at 4-μm thickness for collection of every fifth section. The sections were stained with hematoxylin-eosin. The serial sections were observed with a light microscope system (BZ-8000, Keyence, Tokyo, Japan) and saved as digital images. A digital image of the whole thyroid was reconstructed and the volume was measured using three-dimensional reconstruction software, ZedView (LEXI, Tokyo, Japan).
One mouse was selected randomly for electron microscopic observation of the thyroid gland from each group of Slc26a4 -/- CCD, Slc26a4 -/- ICD, Slc26a4 +/- CCD and Slc26a4 +/- ICD. The electron microscopic observation was done according to the method described previously . Two-mm3 thyroid specimens were excised, fixed in 2.5% glutaraldehyde for 24 hours at 4°C, washed in 0.1M phosphate buffer (pH = 7.0), and fixed again in 1% osmium tetroxide for 3 hours at 4°C. The samples were dehydrated in a graded series of ethanol and embedded in epoxy resin. Ultrathin sections were cut, double stained with uranyl acetate and lead citrate, and examined using a JEOL JEM100S electron microscope (JEOL, Tokyo, Japan).
Statistical analysis was performed using SPSS Statistics ver.19.0 (SPSS Inc., Chicago, IL). One-way ANOVA and Mann-Whitney U-testing were used for statistical analysis. A P value less than 0.05 defined a significant difference.
Volume of thyroid gland
Serum thyroid hormone levels
Serum concentrations of TT3 and TT4 in each animal are shown in Table 1. In the CCD group, the average TT3 levels were 1.26 μg/dl, 1.39 μg/dl and 1.53 μg/dl in Slc26a4 -/- , Slc26a4 +/- and Slc26a4 +/+ mice, respectively. In the ICD group, the average TT3 levels were 0.92 μg/dl, 0.93 μg/dl and 1.07 μg/dl in Slc26a4 -/- , Slc26a4 +/- and Slc26a4 +/+ mice, respectively. The average TT4 levels in the CCD group were 5.25 μg/dl, 5.33 μg/dl and 5.13 μg/dl in Slc26a4 -/- , Slc26a4 +/- and Slc26a4 +/+ mice, respectively. The average TT4 levels in the ICD group were 3.11 μg/dl, 3.07 μg/dl and 4.31 μg/dl in Slc26a4 -/- , Slc26a4 +/- and Slc26a4 +/+ mice, respectively. One-way ANOVA did not reveal a significant difference in TT3 and TT4 levels among the three genotypes.
Mutations of the SLC26A4 (PDS) gene can cause sensorineural hearing loss with goiter (PDS) or non-syndromic recessive deafness with enlarged vestibular aqueduct [5, 6]. To date, more than 150 mutations in the SLC26A4 gene have been reported in patients with PDS or nonsyndromic deafness with enlarged vestibular aqueducts (http://www.healthcare.uiowa.edu/labs/pendredandbor/slcMutations.htm). According to previous reports, the H723R missense substitution accounts for up to 75% of SLC26A4 mutations in Japanese families with EVA [6, 7]. There are many cases without goiter associated with the H723R mutation . Madeo et al. found that thyroid gland volume is primarily SLC26A4 genotype-dependent in children but is age-dependent in adults . These reports suggest that the variable degree of thyroid dysfunction and goiter associated with SLC26A4 mutations may be caused by factors unrelated to SLC26A4 genotype. It is noteworthy that reported homozygotes for the H723R mutation were mainly from Japan and Korea where daily iodine intake should be comparatively high [3, 7, 9]. We therefore hypothesized that the amount of iodine intake influences the thyroid phenotype associated with PDS, leading us to study the effect of dietary iodine deficiency on thyroid gland structure and function in Slc26a4-null mutant mice.
TT4 levels were lower in the ICD group than in the CCD group. This difference was observed regardless of genotype, and these results suggest the thyroid function of Slc26a4-/- mice is approximately the same as of Slc26a4+/- and Slc26a4+/+ mice. While we were preparing the manuscript, we found a similar report by Calebiro et al . In their report they also confirmed that dietary iodine restriction did not induce goiter in Slc26a4-/- mice. However, Calebiro et al. reported that total TT4 levels did not differ significantly between mice fed a low-iodine diet in comparison to those fed a standard diet .
The reason why TT3 levels did not decrease might be because incompletely iodinated thyroglobulin (Tg) in the thyroid colloid is accompanied by an increase in monoiodotyrosine (MIT) on Tg molecules, resulting in preferential T3 synthesis . Therefore, TT3 levels may have been maintained despite the decline in TT4 levels in iodine-deficient mice. Another explanation why TT3 was unchanged in mice fed an iodine-deficient diet is an increase of type 1 iodothyronine 5'-deiodinase (D1) activity in the thyroid gland. Pedraza et al. reported that thyroidal D1 activity was increased with an iodine-deficient diet .
Other factors may compensate for defective iodine transport in both patients with PDS and Slc26a4-/- mice. Van den Hove et al. have reported that the ClCn5 (chloride channel 5) protein localizes at the apical membrane of thyrocytes. The thyroidal phenotype in ClCn5-deficient mice is similar to that in Pendred syndrome, suggesting that ClCn5 could participate in mediating apical iodine efflux or iodine/chloride exchange [13, 14]. Suzuki et al. reported that thyroglobulin, by mediating differential expression of several thyroid-specific genes including TSHR, NIS, and TPO, TG, PAX8, TTF1, and TTF2 regulates the rate of iodide efflux into the follicular lumen and may thus play an important role in regulating thyroid function under constant levels of TSH [13, 15].
In conclusion, the ICD did not induce goiter in Slc26a4-null mice whereas, in humans, SLC26A4 mutations sometimes lead to goiter and even hypothyroidism. Mice may be different from humans in their ability to transport iodide into the follicular lumen or mice may respond differently to altered iodine availability. It is also possible that our results result from the use of male experimental animals since goiter and hypothyroidism are more prevalent among human females than males. The genetic strain background may also influence the penetrance and expressivity of the thyroid phenotype associated with Slc26a4 mutations. These may be some of the factors involved in the development of goiter in PDS.
This study was supported by research grants from the Ministry of Health, Labor, and Welfare and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Slc26a4-null mice were kindly provided by NIH. Andrew Griffith was supported by NIH intramural research fund Z01-DC-000060.
- Kopp P, Pesce L, Solis-S J: Pendred syndrome and iodide transport in the thyroid. Trends Endocrinol Metab 2008, 19: 260–268. 10.1016/j.tem.2008.07.001View ArticlePubMedGoogle Scholar
- Everett L, Belyantseva I, Noben-Trauth K, Cantos R, Chen A, Thakkar S, Hoogstraten-Miller S, Kachar B, Wu D, Green E: Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome. Hum Mol Genet 2001, 10: 153–161. 10.1093/hmg/10.2.153View ArticlePubMedGoogle Scholar
- Sato E, Nakashima T, Miura Y, Furuhashi A, Nakayama A, Mori N, Murakami H, Naganawa S, Tadokoro M: Phenotypes associated with replacement of His by Arg in the Pendred syndrome gene. Eur J Endocrinol 2001, 145: 697–703. 10.1530/eje.0.1450697View ArticlePubMedGoogle Scholar
- Kanou Y, Hishinuma A, Tsunekawa K, Seki K, Mizuno Y, Fujisawa H, Imai T, Miura Y, Nagasaka T, Yamada C, Ieiri T, Murakami M, Murata Y: Thyroglobulin gene mutations producing defective intracellular transport of thyroglobulin are associated with increased thyroidal type 2 iodothyronine deiodinase activity. J Clin Endocrinol Metab 2007, 92: 1451–1457. 10.1210/jc.2006-1242View ArticlePubMedGoogle Scholar
- Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED: Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997, 17: 411–422. 10.1038/ng1297-411View ArticlePubMedGoogle Scholar
- Usami S, Abe S, Weston M, Shinkawa H, Van Camp G, Kimberling W: Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations. Hum Genet 1999, 104: 188–192. 10.1007/s004390050933View ArticlePubMedGoogle Scholar
- Kitamura K, Takahashi K, Noguchi Y, Kuroishikawa Y, Tamagawa Y, Ishikawa K, Ichimura K, Hagiwara H: Mutations of the Pendred syndrome gene (PDS) in patients with large vestibular aqueduct. Acta Otolaryngol 2000, 120: 137–141. 10.1080/000164800750000775View ArticlePubMedGoogle Scholar
- Manichaikul A, Reynolds J, Sarlis NJ, Pryor SP, Shawker T, Griffith AJ: Evaluation of the thyroid in patients with hearing loss and enlarged vestibular aqueducts. Arch Otolaryngol Head Neck Surg 2009, 135: 670–676. 10.1001/archoto.2009.66View ArticlePubMedGoogle Scholar
- Park H-J, Shaukat S, Liu X-Z, Hahn SH, Naz S, Ghosh M, Kim H-N, Moon S-K, Abe S, Tukamoto K, Riazuddin S, Kabra M, Erdenetungalag R, Radnaabazar J, Khan S, Pandya A, Usami S-I, Nance WE, Wilcox ER, Riazuddin S, Griffith AJ: Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness. J Med Genet 2003, 40: 242–248. 10.1136/jmg.40.4.242View ArticlePubMedGoogle Scholar
- Calebiro D, Porazzi P, Bonomi M, Lisi S, Grindati A, De Nittis D, Fugazzola L, Marinò M, Bottà G, Persani L: Absence of primary hypothyroidism and goiter in Slc26a4 (-/-) Mice Fed on a Low Iodine Diet. J Endocrinol Invest 2010.Google Scholar
- Delange F: The disorders induced by iodine deficiency. Thyroid 1994, 4: 107–128. 10.1089/thy.1994.4.107View ArticlePubMedGoogle Scholar
- Pedraza PE, Obregon MJ, Escobar-Morreale HF, del Rey FE, de Escobar GM: Mechanisms of adaptation to iodine deficiency in rats: thyroid status is tissue specific. Its relevance for man. Endocrinology 2006, 147: 2098–2108. 10.1210/en.2005-1325View ArticlePubMedGoogle Scholar
- Bizhanova A, Kopp P: Genetics and phenomics of Pendred syndrome. Mol Cell Endocrinol 2010, 322: 83–90. 10.1016/j.mce.2010.03.006View ArticlePubMedGoogle Scholar
- van den Hove M, Croizet-Berger K, Jouret F, Guggino S, Guggino W, Devuyst O, Courtoy P: The loss of the chloride channel, ClC-5, delays apical iodide efflux and induces a euthyroid goiter in the mouse thyroid gland. Endocrinology 2006, 147: 1287–1296.View ArticlePubMedGoogle Scholar
- Suzuki K, Kohn LD: Differential regulation of apical and basal iodide transporters in the thyroid by thyroglobulin. J Endocrinol 2006, 189: 247–255. 10.1677/joe.1.06677View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.